Comparison between Intravenous Injection of Iron Sucrose and Oral Administration of Iron for the Treatment of Iron Deficiency Anemia in Pregnancy

Authors

  • Vineeta Yadav Department of Obstetrics and Gynecology, Rajarajeshwari Medical College, Bengaluru, Karnataka, India
  • R Nagarathanama Department of Obstetrics and Gynecology, Rajarajeshwari Medical College, Bengaluru, Karnataka, India
  • Nagendra Prasad Department of Obstetrics and Gynecology, Rajarajeshwari Medical College, Bengaluru, Karnataka, India

DOI:

https://doi.org/10.37591/rrjos.v5i3.1454

Abstract

The aim of this study was to compare the therapeutic benefits of intravenous iron and oral iron administration for the treatment of iron deficiency anemia (IDA) in pregnancy. A total of 50 patients with gestational age between 25 and 35 weeks with established IDA with Hemoglobin (Hb) 7–9 g/dl were randomized to receive either oral ferrous sulphate 200 mg twice daily or required dose of intravenous iron sucrose 200 mg in 100 ml NS on alternate days. The Hb level, hematocrit, mean corpuscular volume and packed cell volume were measured at recruitment and on 1st week, 3rd week and at 37 weeks. Adverse drug reactions were also noted in both the groups. Hb values varied drastically with time between the two groups at 1st week, 3rd week and at term. Intravenous iron sucrose helped in treating IDA in pregnancy more effectively than oral iron therapy, without any side effects or reactions.

 

Keyword: Iron deficiency anemia (IDA), iron sucrose, oral iron therapy

Cite this Article

Yadav V, Nagarathanama R, Prasad N. Comparison between Intravenous Injection of Iron Sucrose and Oral Administration of Iron for the Treatment of Iron Deficiency Anemia in Pregnancy. Research and Reviews: Journal of Surgery. 2016; 5(3): 25–28p.

Downloads

Published

2019-04-18

Issue

Vol. 5 No. 3 (2016)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have neither given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.